Therapy-related Myelodysplastic Syndromes
Authors:
- Barry RosenbloomBRBarry Rosenbloom
- Rhona SchreckRSRhona Schreck
- H. Phillip KoefflerHKH. Phillip Koeffler
- 1 June 1992
- journal article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 6 (3) , 707-722
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Cytarabine: Low-Dose, High-Dose, No Dose?New England Journal of Medicine, 1983
- Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)New England Journal of Medicine, 1983
- Acute Nonlymphocytic Leukemia after Therapy with Alkylating Agents for Ovarian CancerNew England Journal of Medicine, 1982
- Incidence of Acute Nonlymphocytic Leukemia, Preleukemia, and Acute Myeloproliferative Syndrome up to 10 Years after Treatment of Hodgkin's DiseaseNew England Journal of Medicine, 1982
- Increased Incidence of Acute Leukemia in Polycythemia Vera Associated with Chlorambucil TherapyNew England Journal of Medicine, 1981
- The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute LeukemiaNew England Journal of Medicine, 1979
- Acute leukaemia after busulphan.BMJ, 1977
- Hematologic Neoplasia in Patients Treated for Hodgkin's DiseaseNew England Journal of Medicine, 1977
- Acute Leukemia after Alkylating-Agent Therapy of Ovarian CancerNew England Journal of Medicine, 1977